Covance has launched the new Express Suite of IVR services, designed for use in small, non-complex clinical trials and post-marketing studies, after spotting a gap in the market.
Traditionally, companies running small and simple clinical trials have laboured with error-prone and out-dated manual processes, as newer electronic data capture (EDC) and IVR technologies have been seen as too expensive, too complex and difficult to get off the ground.
"With the Express Suite, Covance is delivering the best of all worlds - a fast start-up, affordable, off-the-shelf solution, with the benefit of EDC, analysis, and reporting, all backed by Covance's extensive clinical expertise," said Jim Denmark, general manager of Covance IVRS.
The Express Suite consists of several functionalities built in to serve the most common patient enrollment, randomisation, and drug supply management needs of biopharma firms sponsoring clinical studies, who have until now found automated methods unaffordable, said the company.
Suitable for studies with less than fifty investigator sites, up to five drug supply depots and a duration of two years, sponsors can use the system to view patient and drug supply activity and monitor progress, anticipate problems, and take preventive actions.
Because custom programming is not required, the implementation process is much faster than for custom-built systems, said the company.